Clinical trials
Phase 4 Seizures trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 5 |
| 2015 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Rhode Island Hospital | 2 |
| University of Cincinnati | 2 |
| University of Michigan | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Azurity Pharmaceuticals | 1 |
| Boston Children's Hospital | 1 |
| Boston VA Research Institute, Inc. | 1 |
| Carilion Clinic | 1 |
| Children's National Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seizures | 32 |
| Epilepsy | 15 |
| Epilepsies, Partial | 3 |
| Brain Injuries, Traumatic | 2 |
| Brain Neoplasms | 2 |
| Conversion Disorder | 2 |
| Epilepsy, Tonic-Clonic | 2 |
| Intracranial Aneurysm | 2 |
| Psychogenic Nonepileptic Seizures | 2 |
| Stress Disorders, Post-Traumatic | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.